Qing Li

Biography

Qing Li, PhD, Professor in Pharmacology and Immunology, Executive Director of Center for Cellular, Chemical and Structural Biology. Dr. Li received his PhD degree from the Chinese University of Hong Kong in 2004. His PhD project was to investigate the functional roles of a highly conserved protein, BRE, whose function at the time was unknown. His work established BRE as a death receptor-associated anti-apoptotic protein which can promote tumor growth in vivo. Dr. Li subsequently took his postdoctoral training in Stanford University under the mentorship of world’s most respected scientist, Prof. Hugh McDevitt. His discovery of interferon-alpha as a crucial early driver of type-1 diabetes will no doubt open new avenues for the understanding and treatment of this important, enigmatic autoimmune disease. In 2012, Dr. Li collaborated with world’s leading scientist, Nobel Prize Laureate, Prof. Roger Kornberg, and successfully obtained the grant of Introduced Innovative R&D Team Leadership of Guangdong Province. In the same year, Dr. Li joined the School of Pharmacology, Sun Yat-sen university, as a professor. Dr. Li’s research interests focus on the mechanism underlying the development of type-1 diabetes, and micro-environment study of tumor. The major goal of Li Lab is to develop innovative large molecules, including monoclonal antibodies and recombinant proteins, to treat autoimmune diseases and cancers.

Research Interest

Type-1 Diabetes, and Micro-environment study of Tumor